These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9657224

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A simple assay for the simultaneous determination of human plasma albendazole and albendazole sulfoxide levels by high performance liquid chromatography in tandem mass spectrometry with solid-phase extraction.
    Wojnicz A, Cabaleiro-Ocampo T, Román-Martínez M, Ochoa-Mazarro D, Abad-Santos F, Ruiz-Nuño A.
    Clin Chim Acta; 2013 Nov 15; 426():58-63. PubMed ID: 24008168
    [Abstract] [Full Text] [Related]

  • 23. Separation of albendazole sulfoxide enantiomers by chiral supercritical-fluid chromatography.
    del Nozal MJ, Toribio L, Bernal JL, Nieto EM, Jiménez JJ.
    J Biochem Biophys Methods; 2002 Dec 31; 54(1-3):339-45. PubMed ID: 12543509
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
    Li Z, Chen C, Ai D, Wang C, Li J, Qi Y, Yi W, Shen H, Cao J.
    Environ Toxicol Pharmacol; 2012 Mar 31; 33(2):197-204. PubMed ID: 22227164
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Determination of albendazole sulfoxide in human plasma by using liquid chromatography-tandem mass spectrometry.
    Saraner N, Özkan GY, Güney B, Alkan E, Burul-Bozkurt N, Sağlam O, Fikirdeşici E, Yıldırım M.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun 01; 1022():1-5. PubMed ID: 27060508
    [Abstract] [Full Text] [Related]

  • 27. Determination of albendazole and its metabolites in the muscle tissue of hybrid striped and largemouth bass using liquid chromatography with fluorescence detection.
    Rummel N, Shaikh B.
    J AOAC Int; 2008 Jun 01; 91(2):469-77. PubMed ID: 18476362
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis.
    Marques MP, Takayanagui OM, Bonato PS, Santos SR, Lanchote VL.
    Chirality; 1999 Jun 01; 11(3):218-23. PubMed ID: 10079501
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Influence of mobile phase composition on chiral separation of albendazole sulfoxide racemates].
    Zhai Z, Zhang H, Dun H, Liu C, Chen L, Li Y.
    Se Pu; 2004 May 01; 22(3):244-7. PubMed ID: 15712908
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
    Lanchote VL, Garcia FS, Dreossi SA, Takayanagui OM.
    Ther Drug Monit; 2002 Jun 01; 24(3):338-45. PubMed ID: 12021623
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis.
    Lanchote VL, Takayanagui OM, Mateus FH.
    Chirality; 2004 Oct 01; 16(8):520-5. PubMed ID: 15290687
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.